Clinical Trial Update: Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome) [Phase 4]

View source ↗

Summary

A single-center Phase 4 randomized, double-blind trial in healthy subjects or patients with Gitelman syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gitelman Syndrome
• Hypokalemia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gitelman Syndrome, Potassium Depletion | Phase 4 | Status: COMPLETED